← Back to Clinical Trials
Recruiting NCT07034274
NCT07034274 National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT07034274 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dacima Consulting |
| Condition | Secondary Prevention |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2025-06-09 |
| Primary Completion | 2025-07-31 |
Trial Parameters
Condition Secondary Prevention
Sponsor Dacima Consulting
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5,000
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2025-06-09
Completion 2025-07-31
All Conditions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
A non-interventional, national longitudinal multicenter study of CV secondary prevention in Tunisia
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years and \< 80 years * Patients who have been hospitalized for at least one acute coronary event with coronary revascularization, either percutaneous or surgical by coronary artery bypass grafting, or who have confirmed coronary artery disease requiring optimal medical treatment for more than 6 months * Coronary event happening in 2024 * Informed, read and signed consent Exclusion Criteria: * Familial hypercholesterolemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology